Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 337 to 346 of 346 entries
Sorted by: Best Match Show Resources per page
The critical role of the aldehyde dehydrogenase PauC in spermine, spermidine, and diaminopropane toxicity in Pseudomonas aeruginosa: Its possible use as a drug target.

The FEBS journal

Cardona-Cardona YV, Regla I, Juárez-Díaz JA, Carrillo-Campos J, López-Ortiz M, Aguilera-Cruz A, Mújica-Jiménez C, Muñoz-Clares RA.
PMID: 34767295
FEBS J. 2021 Nov 12; doi: 10.1111/febs.16277. Epub 2021 Nov 12.

The opportunistic human pathogen Pseudomonas aeruginosa exhibits great resistance to antibiotics; so, new therapeutic agents are urgently needed. Since polyamines levels are incremented in infected tissues, we explored whether the formation of a toxic aldehyde in polyamines degradation can...

Cite
Cardona-Cardona YV, Regla I, Juárez-Díaz JA, et al. The critical role of the aldehyde dehydrogenase PauC in spermine, spermidine, and diaminopropane toxicity in Pseudomonas aeruginosa: Its possible use as a drug target. FEBS J. 2021;doi: 10.1111/febs.16277.
Cardona-Cardona, Y. V., Regla, I., Juárez-Díaz, J. A., Carrillo-Campos, J., López-Ortiz, M., Aguilera-Cruz, A., Mújica-Jiménez, C., & Muñoz-Clares, R. A. (2021). The critical role of the aldehyde dehydrogenase PauC in spermine, spermidine, and diaminopropane toxicity in Pseudomonas aeruginosa: Its possible use as a drug target. The FEBS journal, . https://doi.org/10.1111/febs.16277
Cardona-Cardona, Yudy V, et al. "The critical role of the aldehyde dehydrogenase PauC in spermine, spermidine, and diaminopropane toxicity in Pseudomonas aeruginosa: Its possible use as a drug target." The FEBS journal vol. (2021). doi: https://doi.org/10.1111/febs.16277
Cardona-Cardona YV, Regla I, Juárez-Díaz JA, Carrillo-Campos J, López-Ortiz M, Aguilera-Cruz A, Mújica-Jiménez C, Muñoz-Clares RA. The critical role of the aldehyde dehydrogenase PauC in spermine, spermidine, and diaminopropane toxicity in Pseudomonas aeruginosa: Its possible use as a drug target. FEBS J. 2021 Nov 12; doi: 10.1111/febs.16277. Epub 2021 Nov 12. PMID: 34767295.
Copy Download .nbib Format: NLM
The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review.

Journal of biomechanical engineering

Eisner LE, Rosario R, Andarawis-Puri N, Arruda EM.
PMID: 34802057
J Biomech Eng. 2021 Nov 21; doi: 10.1115/1.4053086. Epub 2021 Nov 21.

Tendon is a connective tissue that transmits loads from muscle to bone, while ligament is a similar tissue that stabilizes joint articulation by connecting bone to bone. 70-90% of tendon and ligament's extracellular matrix (ECM) is composed of a...

Cite
Eisner LE, Rosario R, Andarawis-Puri N, et al. The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review. J Biomech Eng. 2021;doi: 10.1115/1.4053086.
Eisner, L. E., Rosario, R., Andarawis-Puri, N., & Arruda, E. M. (2021). The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review. Journal of biomechanical engineering, . https://doi.org/10.1115/1.4053086
Eisner, Lainie E, et al. "The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review." Journal of biomechanical engineering vol. (2021). doi: https://doi.org/10.1115/1.4053086
Eisner LE, Rosario R, Andarawis-Puri N, Arruda EM. The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review. J Biomech Eng. 2021 Nov 21; doi: 10.1115/1.4053086. Epub 2021 Nov 21. PMID: 34802057.
Copy Download .nbib Format: NLM
A Non-Coding RNA Network Involved in KSHV Tumorigenesis.

Frontiers in oncology

Naipauer J, García Solá ME, Salyakina D, Rosario S, Williams S, Coso O, Abba MC, Mesri EA, Lacunza E.
PMID: 34222014
Front Oncol. 2021 Jun 16;11:687629. doi: 10.3389/fonc.2021.687629. eCollection 2021.

Regulatory pathways involving non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNA), have gained great relevance due to their role in the control of gene expression modulation. Using RNA sequencing of KSHV Bac36 transfected mouse endothelial...

Cite
Naipauer J, García Solá ME, Salyakina D, et al. A Non-Coding RNA Network Involved in KSHV Tumorigenesis. Front Oncol. 2021;11:687629doi: 10.3389/fonc.2021.687629.
Naipauer, J., García Solá, M. E., Salyakina, D., Rosario, S., Williams, S., Coso, O., Abba, M. C., Mesri, E. A., & Lacunza, E. (2021). A Non-Coding RNA Network Involved in KSHV Tumorigenesis. Frontiers in oncology, 11687629. https://doi.org/10.3389/fonc.2021.687629
Naipauer, Julián, et al. "A Non-Coding RNA Network Involved in KSHV Tumorigenesis." Frontiers in oncology vol. 11 (2021): 687629. doi: https://doi.org/10.3389/fonc.2021.687629
Naipauer J, García Solá ME, Salyakina D, Rosario S, Williams S, Coso O, Abba MC, Mesri EA, Lacunza E. A Non-Coding RNA Network Involved in KSHV Tumorigenesis. Front Oncol. 2021 Jun 16;11:687629. doi: 10.3389/fonc.2021.687629. eCollection 2021. PMID: 34222014; PMCID: PMC8242244.
Copy Download .nbib Format: NLM
Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.

Cell reports

Rosario D, Bidkhori G, Lee S, Bedarf J, Hildebrand F, Le Chatelier E, Uhlen M, Ehrlich SD, Proctor G, Wüllner U, Mardinoglu A, Shoaie S.
PMID: 33657381
Cell Rep. 2021 Mar 02;34(9):108807. doi: 10.1016/j.celrep.2021.108807.

Parkinson's disease (PD) is the most common progressive neurological disorder compromising motor functions. However, nonmotor symptoms, such as gastrointestinal (GI) dysfunction, precede those affecting movement. Evidence of an early involvement of the GI tract and enteric nervous system highlights...

Cite
Rosario D, Bidkhori G, Lee S, et al. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease. Cell Rep. 2021;34(9):108807doi: 10.1016/j.celrep.2021.108807.
Rosario, D., Bidkhori, G., Lee, S., Bedarf, J., Hildebrand, F., Le Chatelier, E., Uhlen, M., Ehrlich, S. D., Proctor, G., Wüllner, U., Mardinoglu, A., & Shoaie, S. (2021). Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease. Cell reports, 34(9), 108807. https://doi.org/10.1016/j.celrep.2021.108807
Rosario, Dorines, et al. "Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease." Cell reports vol. 34,9 (2021): 108807. doi: https://doi.org/10.1016/j.celrep.2021.108807
Rosario D, Bidkhori G, Lee S, Bedarf J, Hildebrand F, Le Chatelier E, Uhlen M, Ehrlich SD, Proctor G, Wüllner U, Mardinoglu A, Shoaie S. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease. Cell Rep. 2021 Mar 02;34(9):108807. doi: 10.1016/j.celrep.2021.108807. PMID: 33657381.
Copy Download .nbib Format: NLM
Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report.

Frontiers in neurology

Rosafio F, Bigliardi G, Lelli N, Vandelli L, Naldi F, Ciolli L, Meletti S, Zini A.
PMID: 34447344
Front Neurol. 2021 Aug 10;12:663308. doi: 10.3389/fneur.2021.663308. eCollection 2021.

No abstract available.

Cite
Rosafio F, Bigliardi G, Lelli N, et al. Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report. Front Neurol. 2021;12:663308doi: 10.3389/fneur.2021.663308.
Rosafio, F., Bigliardi, G., Lelli, N., Vandelli, L., Naldi, F., Ciolli, L., Meletti, S., & Zini, A. (2021). Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report. Frontiers in neurology, 12663308. https://doi.org/10.3389/fneur.2021.663308
Rosafio, Francesca, et al. "Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report." Frontiers in neurology vol. 12 (2021): 663308. doi: https://doi.org/10.3389/fneur.2021.663308
Rosafio F, Bigliardi G, Lelli N, Vandelli L, Naldi F, Ciolli L, Meletti S, Zini A. Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report. Front Neurol. 2021 Aug 10;12:663308. doi: 10.3389/fneur.2021.663308. eCollection 2021. PMID: 34447344; PMCID: PMC8383200.
Copy Download .nbib Format: NLM
Exercise Capacity in Young Adults Born Small for Gestational Age.

JAMA cardiology

Crispi F, Rodríguez-López M, Bernardino G, Sepúlveda-Martínez Á, Prat-González S, Pajuelo C, Perea RJ, Caralt MT, Casu G, Vellvé K, Crovetto F, Burgos F, De Craene M, Butakoff C, González Ballester MÁ, Blanco I, Sitges M, Bijnens B, Gratacós E.
PMID: 34287644
JAMA Cardiol. 2021 Nov 01;6(11):1308-1316. doi: 10.1001/jamacardio.2021.2537.

IMPORTANCE: Being born small for gestational age (SGA), approximately 10% of all births, is associated with increased risk of cardiovascular mortality in adulthood, but mechanistic pathways are unclear. Cardiac remodeling and dysfunction occur in fetuses SGA and children born...

Cite
Crispi F, Rodríguez-López M, Bernardino G, et al. Exercise Capacity in Young Adults Born Small for Gestational Age. JAMA Cardiol. 2021;6(11):1308-1316doi: 10.1001/jamacardio.2021.2537.
Crispi, F., Rodríguez-López, M., Bernardino, G., Sepúlveda-Martínez, �. �., Prat-González, S., Pajuelo, C., Perea, R. J., Caralt, M. T., Casu, G., Vellvé, K., Crovetto, F., Burgos, F., De Craene, M., Butakoff, C., González Ballester, M. �. �., Blanco, I., Sitges, M., Bijnens, B., & Gratacós, E. (2021). Exercise Capacity in Young Adults Born Small for Gestational Age. JAMA cardiology, 6(11), 1308-1316. https://doi.org/10.1001/jamacardio.2021.2537
Crispi, Fàtima, et al. "Exercise Capacity in Young Adults Born Small for Gestational Age." JAMA cardiology vol. 6,11 (2021): 1308-1316. doi: https://doi.org/10.1001/jamacardio.2021.2537
Crispi F, Rodríguez-López M, Bernardino G, Sepúlveda-Martínez Á, Prat-González S, Pajuelo C, Perea RJ, Caralt MT, Casu G, Vellvé K, Crovetto F, Burgos F, De Craene M, Butakoff C, González Ballester MÁ, Blanco I, Sitges M, Bijnens B, Gratacós E. Exercise Capacity in Young Adults Born Small for Gestational Age. JAMA Cardiol. 2021 Nov 01;6(11):1308-1316. doi: 10.1001/jamacardio.2021.2537. PMID: 34287644; PMCID: PMC8576583.
Copy Download .nbib Format: NLM
The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review.

Journal of biomechanical engineering

Eisner LE, Rosario R, Andarawis-Puri N, Arruda EM.
PMID: 34802057
J Biomech Eng. 2022 May 01;144(5). doi: 10.1115/1.4053086.

Tendon is a connective tissue that transmits loads from muscle to bone, while ligament is a similar tissue that stabilizes joint articulation by connecting bone to bone. The 70-90% of tendon and ligament's extracellular matrix (ECM) is composed of...

Cite
Eisner LE, Rosario R, Andarawis-Puri N, et al. The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review. J Biomech Eng. 2022;144(5)doi: 10.1115/1.4053086.
Eisner, L. E., Rosario, R., Andarawis-Puri, N., & Arruda, E. M. (2022). The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review. Journal of biomechanical engineering, 144(5), . https://doi.org/10.1115/1.4053086
Eisner, Lainie E, et al. "The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review." Journal of biomechanical engineering vol. 144,5 (2022). doi: https://doi.org/10.1115/1.4053086
Eisner LE, Rosario R, Andarawis-Puri N, Arruda EM. The Role of the Non-Collagenous Extracellular Matrix in Tendon and Ligament Mechanical Behavior: A Review. J Biomech Eng. 2022 May 01;144(5). doi: 10.1115/1.4053086. PMID: 34802057.
Copy Download .nbib Format: NLM
Replacement of an endocarditic bioprosthetic pulmonary valve with a monocusp cryopreserved pulmonary artery patch.

JTCVS techniques

García-Rinaldi R, Becerra-Román I, Rosario C, Olmeda S, Reyes-Torres P.
PMID: 34318146
JTCVS Tech. 2021 Jan 13;6:68-70. doi: 10.1016/j.xjtc.2021.01.009. eCollection 2021 Apr.

No abstract available.

Cite
García-Rinaldi R, Becerra-Román I, Rosario C, et al. Replacement of an endocarditic bioprosthetic pulmonary valve with a monocusp cryopreserved pulmonary artery patch. JTCVS Tech. 2021;6:68-70doi: 10.1016/j.xjtc.2021.01.009.
García-Rinaldi, R., Becerra-Román, I., Rosario, C., Olmeda, S., & Reyes-Torres, P. (2021). Replacement of an endocarditic bioprosthetic pulmonary valve with a monocusp cryopreserved pulmonary artery patch. JTCVS techniques, 668-70. https://doi.org/10.1016/j.xjtc.2021.01.009
García-Rinaldi, Raúl, et al. "Replacement of an endocarditic bioprosthetic pulmonary valve with a monocusp cryopreserved pulmonary artery patch." JTCVS techniques vol. 6 (2021): 68-70. doi: https://doi.org/10.1016/j.xjtc.2021.01.009
García-Rinaldi R, Becerra-Román I, Rosario C, Olmeda S, Reyes-Torres P. Replacement of an endocarditic bioprosthetic pulmonary valve with a monocusp cryopreserved pulmonary artery patch. JTCVS Tech. 2021 Jan 13;6:68-70. doi: 10.1016/j.xjtc.2021.01.009. eCollection 2021 Apr. PMID: 34318146; PMCID: PMC8300967.
Copy Download .nbib Format: NLM
Incidence and causes of neonatal hyperbilirubinemia in a center of Catania.

Therapeutics and clinical risk management

Sciuto M, Bertino G, Zocco M, Vecchio I, Raffaele R, Trifiletti RR, Pavone P.
PMID: 19436609
Ther Clin Risk Manag. 2009 Feb;5(1):247-50. doi: 10.2147/tcrm.s4509. Epub 2009 Mar 26.

AIM AND SCOPE: We conducted this study to estimate the incidence of hyperbilirubinemia in a small neonatal care unit in Catania, Italy, and to determine the underlying causes, which would be of value in identifying and implementing strategies to...

Cite
Sciuto M, Bertino G, Zocco M, et al. Incidence and causes of neonatal hyperbilirubinemia in a center of Catania. Ther Clin Risk Manag. 2009;5(1):247-50doi: 10.2147/tcrm.s4509.
Sciuto, M., Bertino, G., Zocco, M., Vecchio, I., Raffaele, R., Trifiletti, R. R., & Pavone, P. (2009). Incidence and causes of neonatal hyperbilirubinemia in a center of Catania. Therapeutics and clinical risk management, 5(1), 247-50. https://doi.org/10.2147/tcrm.s4509
Sciuto, Marco, et al. "Incidence and causes of neonatal hyperbilirubinemia in a center of Catania." Therapeutics and clinical risk management vol. 5,1 (2009): 247-50. doi: https://doi.org/10.2147/tcrm.s4509
Sciuto M, Bertino G, Zocco M, Vecchio I, Raffaele R, Trifiletti RR, Pavone P. Incidence and causes of neonatal hyperbilirubinemia in a center of Catania. Ther Clin Risk Manag. 2009 Feb;5(1):247-50. doi: 10.2147/tcrm.s4509. Epub 2009 Mar 26. PMID: 19436609; PMCID: PMC2697514.
Copy Download .nbib Format: NLM
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.

Journal of Crohn's & colitis

Vermeire S, D'Haens G, Baert F, Danese S, Kobayashi T, Loftus EV, Bhatia S, Agboton C, Rosario M, Chen C, Zhang W, Kisfalvi K, Sandborn WJ.
PMID: 34402887
J Crohns Colitis. 2021 Aug 17; doi: 10.1093/ecco-jcc/jjab133. Epub 2021 Aug 17.

BACKGROUND AND AIMS: Report results from VISIBLE 2, a randomised, double-blind, placebo-controlled phase 3 trial evaluating a new subcutaneous [SC] vedolizumab formulation as maintenance treatment in adults with moderately to severely active Crohn's disease [CD].METHODS: Following open-label vedolizumab 300...

Cite
Vermeire S, D'Haens G, Baert F, et al. Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial. J Crohns Colitis. 2021;doi: 10.1093/ecco-jcc/jjab133.
Vermeire, S., D'Haens, G., Baert, F., Danese, S., Kobayashi, T., Loftus, E. V., Bhatia, S., Agboton, C., Rosario, M., Chen, C., Zhang, W., Kisfalvi, K., & Sandborn, W. J. (2021). Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjab133
Vermeire, Séverine, et al. "Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial." Journal of Crohn's & colitis vol. (2021). doi: https://doi.org/10.1093/ecco-jcc/jjab133
Vermeire S, D'Haens G, Baert F, Danese S, Kobayashi T, Loftus EV, Bhatia S, Agboton C, Rosario M, Chen C, Zhang W, Kisfalvi K, Sandborn WJ. Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial. J Crohns Colitis. 2021 Aug 17; doi: 10.1093/ecco-jcc/jjab133. Epub 2021 Aug 17. PMID: 34402887.
Copy Download .nbib Format: NLM
Showing 337 to 346 of 346 entries